Molecular Mechanisms and Cell Targets of Th17 Cells in the Gastrointestinal Tract: An Innate Sense of Adaptivity

REFERENCES

• Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007;449(7164):819–826.
   PubMed Web of Science ®Google Scholar
• McGeachy MJ, Chen Y, Tato CM, The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 2009;10(3):314–324.
   PubMed Web of Science ®Google Scholar
• Ghoreschi K, Laurence A, Yang XP, Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 2010;467(7318):967–971.
   PubMed Web of Science ®Google Scholar
• Hernandez-Santos N, Gaffen SL. Th17 cells in immunity to Candida albicans. Cell Host Microbe 2012;11(5):425–435.
   PubMed Web of Science ®Google Scholar
• Puel A, Cypowyj S, Bustamante J, Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011;332(6025):65–68.
   PubMed Web of Science ®Google Scholar
• Puel A, Cypowyj S, Marodi L, Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol 2012;12(6):616–622.
   PubMed Web of Science ®Google Scholar
• McDonald DR. TH17 deficiency in human disease. J Allergy Clin Immunol 2012;129(6):1429–1435; quiz 1436–1437.
   Google Scholar
• Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 2008;226:87–102.
   PubMed Web of Science ®Google Scholar
• Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010;28:573–621.
   PubMed Web of Science ®Google Scholar
• Duerr RH, Taylor KD, Brant SR, A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314(5804):1461–1463.
   PubMed Web of Science ®Google Scholar
• Glas J, Seiderer J, Wetzke M, rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One 2007;2(9):e819.
   PubMed Web of Science ®Google Scholar
• Momozawa Y, Mni M, Nakamura K, Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet 2011;43(1):43–47.
   PubMed Web of Science ®Google Scholar
• Barrett JC, Hansoul S, Nicolae DL, Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40(8):955–962.
   PubMed Web of Science ®Google Scholar
• Fisher SA, Tremelling M, Anderson CA, Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008;40(6):710–712.
   PubMed Web of Science ®Google Scholar
• Franke A, Balschun T, Karlsen TH, Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 2008;40(6):713–715.
   Google Scholar
• Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011;474(7351):307–317.
   PubMed Web of Science ®Google Scholar
• Hueber W, Patel DD, Dryja T, Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2010;2(52):52ra72.
   PubMed Web of Science ®Google Scholar
• Leonardi C, Matheson R, Zachariae C, Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 2012;366(13):1190–1199.
   PubMed Web of Science ®Google Scholar
• Papp KA, Leonardi C, Menter A, Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 2012;366(13):1181–1189.
   PubMed Web of Science ®Google Scholar
• Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012;11(10):763–776.
   PubMed Web of Science ®Google Scholar
• Garber K. Anti-IL-17 mAbs herald new options in psoriasis. Nat Biotechnol 2012;30(6):475–477.
   PubMed Web of Science ®Google Scholar
• Patel DD, Lee DM, Kolbinger F, Antoni C. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis 2013;72(Suppl 2):ii116–ii123.
   PubMed Web of Science ®Google Scholar
• Hueber W, Sands BE, Lewitzky S, Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012;61(12):1693–1700.
   PubMed Web of Science ®Google Scholar
• Symons A, Budelsky AL, Towne JE. Are Th17 cells in the gut pathogenic or protective? Mucosal Immunol 2012;5(1):4–6.
   Google Scholar
• Vermeire S, Rutgeerts P. IBD in 2012: Pathogenesis and management of IBD –thinking outside the box. Nat Rev Gastroenterol Hepatol 2013;10(2):67–69.
   Google Scholar
• Ivanov, II, Frutos Rde L, Manel N, Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008;4(4):337–49.
   PubMed Web of Science ®Google Scholar
• Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 2010;140(6):845–858.
   PubMed Web of Science ®Google Scholar
• Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009;31(4):677–689.
   PubMed Web of Science ®Google Scholar
• Ivanov, II, Atarashi K, Manel N, Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009;139(3):485–498.
   PubMed Web of Science ®Google Scholar
• Roberts S, Gueguen Y, de Lorgeril J, Goetz F. Rapid accumulation of an interleukin 17 homolog transcript in Crassostrea gigas hemocytes following bacterial exposure. Dev Comp Immunol 2008;32(9):1099–1104.
   Google Scholar
• Guo P, Hirano M, Herrin BR, Dual nature of the adaptive immune system in lampreys. Nature 2009;459(7248):796–801.
   PubMed Web of Science ®Google Scholar
• Secombes CJ, Wang T, Bird S. The interleukins of fish. Dev Comp Immunol 2011;35(12):1336–1345.
   PubMed Web of Science ®Google Scholar
• Wu B, Jin M, Zhang Y, Evolution of the IL17 receptor family in chordates: a new subfamily IL17REL. Immunogenetics 2011;63(12):835–845.
   Google Scholar
• Eberl G. Development and evolution of RORgammat+ cells in a microbe's world. Immunol Rev 2012;245(1):177–188.
   Google Scholar
• Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003;14(2):155–174.
   PubMed Web of Science ®Google Scholar
• Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004;21(4):467–476.
   PubMed Web of Science ®Google Scholar
• Yao Z, Fanslow WC, Seldin MF, Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995;3(6):811–821.
   PubMed Web of Science ®Google Scholar
• Yao Z, Spriggs MK, Derry JM, Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 1997;9(11):794–800.
   PubMed Web of Science ®Google Scholar
• Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity 2011;34(2):149–162.
   PubMed Web of Science ®Google Scholar
• Song X, Qian Y. The activation and regulation of IL-17 receptor mediated signaling. Cytokine 2013;62(2):175–182.
   PubMed Web of Science ®Google Scholar
• Li H, Chen J, Huang A, Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 2000;97(2):773–778.
   Google Scholar
• Yamaguchi Y, Fujio K, Shoda H, IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis. J Immunol 2007;179(10):7128–7136.
   PubMed Web of Science ®Google Scholar
• Hymowitz SG, Filvaroff EH, Yin JP, IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 2001;20(19):5332–5341.
   PubMed Web of Science ®Google Scholar
• Starnes T, Robertson MJ, Sledge G, Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol 2001;167(8):4137–4140.
   PubMed Web of Science ®Google Scholar
• Yang XO, Chang SH, Park H, Regulation of inflammatory responses by IL-17F. J Exp Med 2008;205(5):1063–1075.
   PubMed Web of Science ®Google Scholar
• Gomez-Rodriguez J, Sahu N, Handon R, Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase. Immunity 2009;31(4):587–597.
   PubMed Web of Science ®Google Scholar
• Hedrich CM, Rauen T, Kis-Toth K, cAMP-responsive element modulator alpha (CREMalpha) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE). J Biol Chem 2012;287(7):4715–4725.
   PubMed Web of Science ®Google Scholar
• Toy D, Kugler D, Wolfson M, Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 2006;177(1):36–39.
   PubMed Web of Science ®Google Scholar
• Ely LK, Fischer S, Garcia KC. Structural basis of receptor sharing by interleukin 17 cytokines. Nat Immunol 2009;10(12):1245–1251.
   PubMed Web of Science ®Google Scholar
• Liu S, Song X, Chrunyk BA, Crystal structures of interleukin 17A and its complex with IL-17 receptor A. Nat Commun 2013;4:1888.
   PubMed Web of Science ®Google Scholar
• Shen F, Gaffen SL. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 2008;41(2):92–104.
   PubMed Web of Science ®Google Scholar
• Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009;9(8):556–567.
   PubMed Web of Science ®Google Scholar
• Onishi RM, Park SJ, Hanel W, SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction. J Biol Chem 2010;285(43):32751–9.
   Google Scholar
• Leonard WJ, O'Shea JJ. Jaks and STATs: biological implications. Annu Rev Immunol 1998;16:293–322.
   PubMed Web of Science ®Google Scholar
• Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol 2007;178(5): 2623–2629.
   PubMed Web of Science ®Google Scholar
• Shalom-Barak T, Quach J, Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem 1998;273(42):27467–27473.
   PubMed Web of Science ®Google Scholar
• Awane M, Andres PG, Li DJ, Reinecker HC. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol 1999;162(9):5337–5344.
   PubMed Web of Science ®Google Scholar
• Schwandner R, Yamaguchi K, Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 2000;191(7):1233–1240.
   PubMed Web of Science ®Google Scholar
• Ruddy MJ, Wong GC, Liu XK, Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 2004;279(4):2559–2567.
   Google Scholar
• Shen F, Hu Z, Goswami J, Gaffen SL. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 2006;281(34):24138–24148.
   Google Scholar
• Yamazaki S, Muta T, Matsuo S, Takeshige K. Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization. J Biol Chem 2005;280(2):1678–1687.
   Google Scholar
• Shen F, Ruddy MJ, Plamondon P, Gaffen SL. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol 2005;77(3):388–399.
   PubMed Web of Science ®Google Scholar
• Novatchkova M, Leibbrandt A, Werzowa J, The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci 2003;28(5):226–229.
   PubMed Web of Science ®Google Scholar
• Chang SH, Park H, Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 2006;281(47):35603–35607.
   Google Scholar
• Qian Y, Liu C, Hartupee J, The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007;8(3):247–256.
   PubMed Web of Science ®Google Scholar
• Linden A. A role for the cytoplasmic adaptor protein Act1 in mediating IL-17 signaling. Sci STKE 2007;2007(398):re4.
   Google Scholar
• Sonder SU, Saret S, Tang W, IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms. J Biol Chem 2011;286(15):12881–12890.
   Google Scholar
• Liu C, Qian W, Qian Y, Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal 2009;2(92):ra63.
   Google Scholar
• Hartupee J, Liu C, Novotny M, IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 2007;179(6):4135–4141.
   Google Scholar
• Hartupee J, Liu C, Novotny M, IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6. J Immunol 2009;182(3):1660–1666.
   PubMed Web of Science ®Google Scholar
• Bulek K, Liu C, Swaidani S, The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat Immunol 2011;12(9): 844–852.
   Google Scholar
• Sun D, Novotny M, Bulek K, Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat Immunol 2011; 12(9):853–860.
   Google Scholar
• Zhu S, Pan W, Song X, The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat Med 2012;18(7):1077–1086.
   PubMed Web of Science ®Google Scholar
• Shi P, Zhu S, Lin Y, Persistent stimulation with interleukin-17 desensitizes cells through SCFbeta-TrCP-mediated degradation of Act1. Sci Signal 2011;4(197):ra73.
   Google Scholar
• Garg AV, Ahmed M, Vallejo AN, The deubiquitinase a20 mediates feedback inhibition of interleukin-17 receptor signaling. Sci Signal 2013;6(278):ra44.
   Google Scholar
• Spolski R, Leonard WJ. Cytokine mediators of Th17 function. Eur J Immunol 2009;39(3):658–661.
   Google Scholar
• Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ. Helper T cell diversity and plasticity. Curr Opin Immunol 2012;24(3):297–302.
   PubMed Web of Science ®Google Scholar
• Zhou L, Ivanov, II, Spolski R, IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007;8(9):967–974.
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Gao W, IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007;448(7152):484–487.
   PubMed Web of Science ®Google Scholar
• Nurieva R, Yang XO, Martinez G, Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007;448(7152):480–483.
   PubMed Web of Science ®Google Scholar
• Wei L, Laurence A, Elias KM, O'Shea JJ. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 2007;282(48):34605–34610.
   PubMed Web of Science ®Google Scholar
• Yamane H, Paul WE. Cytokines of the gamma(c) family control CD4+ T cell differentiation and function. Nat Immunol 2012;13(11):1037–1044.
   Google Scholar
• Suto A, Kashiwakuma D, Kagami S, Development and characterization of IL-21-producing CD4+ T cells. J Exp Med 2008;205(6):1369–1379.
   Google Scholar
• Sarra M, Monteleone I, Stolfi C, Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Inflamm Bowel Dis 2010;16(8):1332–1339.
   PubMed Web of Science ®Google Scholar
• De Nitto D, Sarra M, Pallone F, Monteleone G. Interleukin-21 triggers effector cell responses in the gut. World J Gastroenterol 2010;16(29):3638–3641.
   Google Scholar
• Liang SC, Tan XY, Luxenberg DP, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006;203(10): 2271–2279.
   PubMed Web of Science ®Google Scholar
• Chung Y, Yang X, Chang SH, Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Res 2006;16(11):902–907.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Danilenko DM, Valdez P, Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007;445(7128):648–651.
   PubMed Web of Science ®Google Scholar
• Ouyang W, Rutz S, Crellin NK, Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 2011;29:71–109.
   PubMed Web of Science ®Google Scholar
• Lejeune D, Dumoutier L, Constantinescu S, Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 2002;277(37):33676–33682.
   PubMed Web of Science ®Google Scholar
• Wolk K, Kunz S, Witte E, IL-22 increases the innate immunity of tissues. Immunity 2004;21(2):241–54.
   PubMed Web of Science ®Google Scholar
• Wilson NJ, Boniface K, Chan JR, Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8(9):950–957.
   PubMed Web of Science ®Google Scholar
• Donnelly RP, Sheikh F, Dickensheets H, Interleukin-26: an IL-10-related cytokine produced by Th17 cells. Cytokine Growth Factor Rev 2010;21(5):393–401.
   Web of Science ®Google Scholar
• Sheikh F, Baurin VV, Lewis-Antes A, Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol 2004;172(4):2006–2010.
   PubMed Web of Science ®Google Scholar
• Hor S, Pirzer H, Dumoutier L, The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains. J Biol Chem 2004;279(32):33343–33351.
   PubMed Web of Science ®Google Scholar
• Raffatellu M, Santos RL, Verhoeven DE, Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008;14(4): 421–428.
   PubMed Web of Science ®Google Scholar
• Dambacher J, Beigel F, Zitzmann K, The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 2009;58(9):1207–1217.
   PubMed Web of Science ®Google Scholar
• Fossiez F, Djossou O, Chomarat P, T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996;183(6):2593–2603.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Valdez PA, Danilenko DM, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008;14(3):282–289.
   PubMed Web of Science ®Google Scholar
• Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010;129(3):311–321.
   PubMed Web of Science ®Google Scholar
• Ye P, Rodriguez FH, Kanaly S, Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001;194(4):519–527.
   PubMed Web of Science ®Google Scholar
• Fournier BM, Parkos CA. The role of neutrophils during intestinal inflammation. Mucosal Immunol 2012;5(4):354–366.
   PubMed Web of Science ®Google Scholar
• Moss AJ, Ryan D, Oakes D, Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction. Am J Cardiol 2005;96(2):177–182.
   Google Scholar
• Lubberts E, Schwarzenberger P, Huang W, Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis. J Immunol 2005;175(5):3360–3368.
   Google Scholar
• Chang SH, Dong C. Signaling of interleukin-17 family cytokines in immunity and inflammation. Cell Signal 2011;23(7):1069–1075.
   PubMed Web of Science ®Google Scholar
• Conti HR, Shen F, Nayyar N, Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009;206(2):299–311.
   PubMed Web of Science ®Google Scholar
• Medina C, Radomski MW. Role of matrix metalloproteinases in intestinal inflammation. J Pharmacol Exp Ther 2006;318(3):933–938.
   PubMed Web of Science ®Google Scholar
• Miljkovic D, Trajkovic V. Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev 2004;15(1):21–32.
   Google Scholar
• Takahashi N, Vanlaere I, de Rycke R, IL-17 produced by Paneth cells drives TNF-induced shock. J Exp Med 2008;205(8):1755–1761.
   Google Scholar
• Zhang Y, Wang H, Ren J, IL-17A synergizes with IFN-gamma to upregulate iNOS and NO production and inhibit chlamydial growth. PLoS One 2012;7(6):e39214.
   Google Scholar
• Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004;113(4):427–437.
   PubMed Web of Science ®Google Scholar
• Lundberg JO, Weitzberg E. Biology of nitrogen oxides in the gastrointestinal tract. Gut 2013;62(4):616–629.
   PubMed Web of Science ®Google Scholar
• Ishigame H, Kakuta S, Nagai T, Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009;30(1):108–119.
   PubMed Web of Science ®Google Scholar
• Rubino SJ, Geddes K, Girardin SE. Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol 2012;33(3):112–118.
   Google Scholar
• Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000;118(6):1001–1011.
   PubMed Web of Science ®Google Scholar
• Liu JZ, Pezeshki M, Raffatellu M. Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm. Cytokine 2009;48(1–2):156–60.
   PubMed Web of Science ®Google Scholar
• Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol 2010;30(2):196–203.
   PubMed Web of Science ®Google Scholar
• Menard S, Cerf-Bensussan N, Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol 2010;3(3):247–259.
   PubMed Web of Science ®Google Scholar
• Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 2013;70(4):631–659.
   PubMed Web of Science ®Google Scholar
• Kebir H, Kreymborg K, Ifergan I, Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007;13(10):1173–1175.
   PubMed Web of Science ®Google Scholar
• Schwartz S, Beaulieu JF, Ruemmele FM. Interleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth. Biochem Biophys Res Commun 2005;337(2):505–509.
   Google Scholar
• Sparna T, Retey J, Schmich K, Genome-wide comparison between IL-17 and combined TNF-alpha/IL-17 induced genes in primary murine hepatocytes. BMC Genomics 2010;11:226.
   PubMed Web of Science ®Google Scholar
• Chiricozzi A, Guttman-Yassky E, Suarez-Farinas M, Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 2011;131(3):677–687.
   PubMed Web of Science ®Google Scholar
• Lee JW, Wang P, Kattah MG, Differential regulation of chemokines by IL-17 in colonic epithelial cells. J Immunol 2008;181(9):6536–6545.
   Google Scholar
• Zepp J, Wu L, Li X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol 2011;32(5):232–239.
   PubMed Web of Science ®Google Scholar
• Ogawa A, Andoh A, Araki Y, Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 2004;110(1):55–62.
   PubMed Web of Science ®Google Scholar
• Cao AT, Yao S, Gong B, Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J Immunol 2012;189(9):4666–4673.
   Google Scholar
• Ramirez-Carrozzi V, Sambandam A, Luis E, IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol 2011;12(12):1159–1166.
   PubMed Web of Science ®Google Scholar
• Reynolds JM, Martinez GJ, Nallaparaju KC, Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C. J Immunol 2012;189(9):4226–4230.
   Google Scholar
• Owyang AM, Zaph C, Wilson EH, Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med 2006;203(4): 843–849.
   PubMed Web of Science ®Google Scholar
• Hot A, Zrioual S, Toh ML, IL-17A- versus IL-17F-induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in rheumatoid synoviocytes. Ann Rheum Dis 2011;70(2):341–348.
   Google Scholar
• Hot A, Miossec P. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann Rheum Dis 2011;70(5):727–732.
   PubMed Web of Science ®Google Scholar
• Pabst O. New concepts in the generation and functions of IgA. Nat Rev Immunol 2012;12(12): 821–832.
   PubMed Web of Science ®Google Scholar
• Aujla SJ, Chan YR, Zheng M, IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008;14(3):275–281.
   PubMed Web of Science ®Google Scholar
• Jaffar Z, Ferrini ME, Herritt LA, Roberts K. Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels. J Immunol 2009;182(8):4507–4511.
   Google Scholar
• Moisan J, Grenningloh R, Bettelli E, Ets-1 is a negative regulator of Th17 differentiation. J Exp Med 2007;204(12):2825–2835.
   PubMed Web of Science ®Google Scholar
• Chen Y, Thai P, Zhao YH, Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 2003;278(19):17036–17043.
   PubMed Web of Science ®Google Scholar
• Kallal LE, Hartigan AJ, Hogaboam CM, Inefficient lymph node sensitization during respiratory viral infection promotes IL-17-mediated lung pathology. J Immunol 2010;185(7):4137–4147.
   Google Scholar
• Bystrom J, Al-Adhoubi N, Al-Bogami M, Th17 lymphocytes in respiratory syncytial virus infection. Viruses 2013;5(3):777–791.
   Google Scholar
• McGuckin MA, Linden SK, Sutton P, Florin TH. Mucin dynamics and enteric pathogens. Nat Rev Microbiol 2011;9(4):265–278.
   PubMed Web of Science ®Google Scholar
• Johansson ME, Sjovall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 2013;10:352–361.
   PubMed Web of Science ®Google Scholar
• Franke A, McGovern DP, Barrett JC, Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010;42(12):1118–1125.
   PubMed Web of Science ®Google Scholar
• Hooper LV, Wong MH, Thelin A, Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001;291(5505):881–884.
   PubMed Web of Science ®Google Scholar
• Sommer F, Backhed F. The gut microbiota - masters of host development and physiology. Nat Rev Microbiol 2013;11(4):227–238.
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Ogawa A, Mizoguchi E, IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008;118(2):534–544.
   PubMed Web of Science ®Google Scholar
• Cha HR, Chang SY, Chang JH, Downregulation of Th17 cells in the small intestine by disruption of gut flora in the absence of retinoic acid. J Immunol 2010;184(12):6799–6806.
   PubMed Web of Science ®Google Scholar
• Kuestner RE, Taft DW, Haran A, Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol 2007;179(8):5462–5473.
   PubMed Web of Science ®Google Scholar
• Jovanovic DV, Di Battista JA, Martel-Pelletier J, IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998;160(7):3513–3521.
   PubMed Web of Science ®Google Scholar
• Feng T, Qin H, Wang L, Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. J Immunol 2011;186(11):6313–6318.
   PubMedGoogle Scholar
• Lin Y, Ritchea S, Logar A, Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 2009;31(5): 799–810.
   Google Scholar
• O'Connor W, Jr., Kamanaka M, Booth CJ, et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009;10(6):603–609.
   PubMed Web of Science ®Google Scholar
• Nakae S, Komiyama Y, Nambu A, Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002;17(3):375–387.
   PubMed Web of Science ®Google Scholar
• Hsu HC, Yang P, Wang J, Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008;9(2):166–175.
   PubMed Web of Science ®Google Scholar
• Doreau A, Belot A, Bastid J, Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 2009;10(7):778–785.
   PubMed Web of Science ®Google Scholar
• Mitsdoerffer M, Lee Y, Jager A, Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci USA 2010;107(32):14292–14297.
   PubMed Web of Science ®Google Scholar
• Sweet RA, Lee SK, Vinuesa CG. Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity. Curr Opin Immunol 2012;24(6):658–664.
   Google Scholar
• Qian Y, Qin J, Cui G, Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 2004;21(4):575–587.
   Google Scholar
• Pisitkun P, Ha HL, Wang H, Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 2012;37(6):1104–1115.
   Google Scholar
• Grogan JL, Ouyang W. A role for Th17 cells in the regulation of tertiary lymphoid follicles. Eur J Immunol 2012;42(9):2255–2262.
   PubMed Web of Science ®Google Scholar
• Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006;6(3):205–217.
   PubMed Web of Science ®Google Scholar
• van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol 2010;10(9):664–674.
   PubMed Web of Science ®Google Scholar
• Peters A, Pitcher LA, Sullivan JM, Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 2011;35(6):986–996.
   PubMed Web of Science ®Google Scholar
• Eberl G, Lochner M. The development of intestinal lymphoid tissues at the interface of self and microbiota. Mucosal Immunol 2009;2(6):478–485.
   Google Scholar
• Pearson C, Uhlig HH, Powrie F. Lymphoid microenvironments and innate lymphoid cells in the gut. Trends Immunol 2012;33(6):289–296.
   Google Scholar
• Lochner M, Ohnmacht C, Presley L, Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells. J Exp Med 2011;208(1): 125–134.
   PubMed Web of Science ®Google Scholar
• Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 2011;12(7):639–646.
   PubMed Web of Science ®Google Scholar
• Bermejo DA, Jackson SW, Gorosito-Serran M, Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells. Nat Immunol 2013;14(5):514–522.
   PubMed Web of Science ®Google Scholar
• Raffatellu M, George MD, Akiyama Y, Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 2009;5(5):476–486.
   PubMed Web of Science ®Google Scholar
• Zenewicz LA, Yancopoulos GD, Valenzuela DM, Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008;29(6):947–957.
   PubMed Web of Science ®Google Scholar
• Pickert G, Neufert C, Leppkes M, STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 2009;206(7):1465–1472.
   PubMed Web of Science ®Google Scholar
• Glocker EO, Kotlarz D, Boztug K, Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009;361(21):2033–2045.
   PubMed Web of Science ®Google Scholar
• Begue B, Verdier J, Rieux-Laucat F, Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol 2011;106(8):1544–1555.
   PubMed Web of Science ®Google Scholar
• Kotlarz D, Beier R, Murugan D, Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 2012;143(2):347–355.
   PubMed Web of Science ®Google Scholar
• Engelhardt KR, Shah N, Faizura-Yeop I, Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol 2013;131(3):825–830.
   PubMed Web of Science ®Google Scholar
• Shah N, Kammermeier J, Elawad M, Glocker EO. Interleukin-10 and interleukin-10-receptor defects in inflammatory bowel disease. Curr Allergy Asthma Rep 2012;12(5):373–379.
   Google Scholar
• Sonnenberg GF, Nair MG, Kirn TJ, Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med 2010;207(6):1293–1305.
   PubMed Web of Science ®Google Scholar
• Mundy R, MacDonald TT, Dougan G, Citrobacter rodentium of mice and man. Cell Microbiol 2005;7(12):1697–1706.
   PubMed Web of Science ®Google Scholar
• Sonnenberg GF, Monticelli LA, Elloso MM, CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 2011;34(1):122–134.
   PubMed Web of Science ®Google Scholar
• Sonnenberg GF, Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 2012;37(4):601–610.
   PubMed Web of Science ®Google Scholar
• Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011;12(1):21–27.
   PubMed Web of Science ®Google Scholar
• Sonnenberg GF, Monticelli LA, Alenghat T, Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012;336(6086):1321–1325.
   PubMed Web of Science ®Google Scholar
• Basu R, O'Quinn DB, Silberger DJ, Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012 37(6):1061–1075.
   Web of Science ®Google Scholar
• von Vietinghoff S, Ley K. IL-17A controls IL-17F production and maintains blood neutrophil counts in mice. J Immunol 2009;183(2):865–873.
   Google Scholar
• Kanai T, Mikami Y, Sujino T, RORgammat-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation. Mucosal Immunol 2012;5(3):240–247.
   Google Scholar
• Izcue A, Hue S, Buonocore S, Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 2008;28(4):559–570.
   Google Scholar
• Ahern PP, Schiering C, Buonocore S, Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 2010;33(2):279–288.
   PubMed Web of Science ®Google Scholar
• Liu Z, Feng BS, Yang SB, Interleukin (IL)-23 suppresses IL-10 in inflammatory bowel disease. J Biol Chem 2012;287(5):3591–3597.
   Google Scholar
• Intlekofer AM, Banerjee A, Takemoto N, Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 2008;321(5887):408–411.
   PubMed Web of Science ®Google Scholar
• Huber S, Gagliani N, Zenewicz LA, IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012;491(7423):259–263.
   PubMed Web of Science ®Google Scholar
• Sutton CE, Mielke LA, Mills KH. IL-17-producing gammadelta T cells and innate lymphoid cells. Eur J Immunol 2012;42(9):2221–2231.
   PubMed Web of Science ®Google Scholar
• Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010;10(7):479–489.
   PubMed Web of Science ®Google Scholar
• Michel ML, Keller AC, Paget C, Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007;204(5):995–1001.
   PubMed Web of Science ®Google Scholar
• Hueber AJ, Asquith DL, Miller AM, Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 2010;184(7):3336–3340.
   Google Scholar
• Lin AM, Rubin CJ, Khandpur R, Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 2011;187(1):490–500.
   PubMed Web of Science ®Google Scholar
• Li L, Huang L, Vergis AL, IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010;120(1):331–342.
   PubMed Web of Science ®Google Scholar
• Werner JL, Gessner MA, Lilly LM, Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection. Infect Immun 2011;79(10):3966–3977.
   PubMed Web of Science ®Google Scholar